CNB Bank Sells 721 Shares of Procter & Gamble Company (The) $PG

CNB Bank lowered its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 4.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 15,470 shares of the company’s stock after selling 721 shares during the quarter. Procter & Gamble comprises about 1.2% of CNB Bank’s investment portfolio, making the stock its 18th biggest position. CNB Bank’s holdings in Procter & Gamble were worth $2,465,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the company. Kingstone Capital Partners Texas LLC boosted its stake in Procter & Gamble by 655,209.0% during the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Nuveen LLC bought a new position in shares of Procter & Gamble during the 1st quarter worth about $1,954,941,000. Price T Rowe Associates Inc. MD increased its holdings in shares of Procter & Gamble by 13.0% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Invesco Ltd. increased its holdings in shares of Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC lifted its stake in shares of Procter & Gamble by 1,875.5% in the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock valued at $280,946,000 after buying an additional 1,674,139 shares during the period. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

Shares of PG stock opened at $152.62 on Friday. Procter & Gamble Company has a 1 year low of $146.96 and a 1 year high of $180.43. The firm’s 50 day moving average is $154.66 and its 200-day moving average is $158.41. The firm has a market capitalization of $357.21 billion, a price-to-earnings ratio of 23.44, a PEG ratio of 4.04 and a beta of 0.36. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $22.39 billion for the quarter, compared to analyst estimates of $22.23 billion. During the same period in the prior year, the business earned $1.93 earnings per share. Procter & Gamble’s quarterly revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Sell-side analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be paid a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Friday, October 24th. Procter & Gamble’s payout ratio is 64.98%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on the company. Wells Fargo & Company decreased their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research report on Thursday, September 25th. Raymond James Financial decreased their price objective on Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a report on Monday, October 20th. UBS Group decreased their price objective on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday, October 8th. Barclays lowered their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. Finally, Evercore ISI restated an “in-line” rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, Procter & Gamble has a consensus rating of “Moderate Buy” and a consensus price target of $171.68.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Jon R. Moeller sold 11,684 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the completion of the sale, the chief executive officer directly owned 319,932 shares of the company’s stock, valued at $48,703,248.36. The trade was a 3.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO Shailesh Jejurikar sold 3,986 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the sale, the chief operating officer directly owned 46,899 shares of the company’s stock, valued at approximately $7,139,434.77. This trade represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 149,763 shares of company stock valued at $23,421,279 over the last 90 days. Company insiders own 0.20% of the company’s stock.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.